산업용 효소 시장 : 예측(2025-2030년)

The industrial enzymes market is expected to grow at a CAGR of 7.16%, reaching a market size of US$12,371.259 million in 2030 from US$8,840.071 million in 2025.

Industrial enzymes are a form of commercial enzymes, which is used across multiple industries, like pharmaceuticals, food & beverages, biofuels, and chemical productions. Various types of industrial enzymes are available across the market, including aminopeptidase, lipases, pectinases, and xylanases, among many others. These enzymes offer multiple benefits in multiple industries. They are fully biodegradable and enhance the efficiency and productivity of processes. Industrial enzymes are also easy to manipulate genetically and offer product recovery. It is also easy and cheaper to produce and reduces the carbon sources.

The growing global demand for the chemical sector will propel the industrial enzymes market expansion during the forecasted timeline. In the chemical industry, industrial enzymes are mainly used in the process of specific catalysts. The global demand for chemicals has witnessed constant growth over the past few years. The American Chemistry Council, Inc., in its report, stated that the volume of chemical output grew by 2.2% in 2024, compared to 2023, which recorded a decline of 1.3% in volume output.

Similarly, BASF SE, a global leader in chemical production, reported in its chemical industry that global chemical production will witness a growth of 2.7% in 2024. The company further stated that in 2024, chemical production, excluding the pharmaceutical sector, in China witnessed a growth of 4%, followed by 3% in other parts of Asia. The South American and European Union regions witnessed a growth of 1.3% and 0.8%, respectively.

Industrial enzymes market drivers

• The increase in the global pharma product landscape is contributing to the industrial enzymes market expansion

In drugs and medicine, various types of enzymes like papain, alteplase, lysozyme, and lipase. These enzymes help in the cure and reduction of various cases like anti-inflammatory, lower cholesterol, and others. The rise in the global drug and pharma industry is expected to boost the global demand for industrial enzymes in the market.

Moreover, the global pharma and drug industry has witnessed a significant increase that can be credited to the increase in the global healthcare infrastructure and the rise in the cases of various diseases. In this global trade of pharmaceutical products, countries like Germany, Switzerland, Ireland, and the USA are among the biggest traders of the products.

Industrial Enzymes Market Geographical Outlook

• North America is witnessing exponential growth during the forecast period.

The United States industrial enzyme market is growing in the coming years due to a favourable business environment where it supports the enzyme manufacturers and users through pro-business policies, advanced biotechnology infrastructure, and increasing demand for sustainable solutions across industries like biofuels, food & beverages, and pharmaceuticals.

Furthermore, the demand for industrial enzymes in the U.S. food and beverage sector will grow as there is an increase in more natural, clean-label, and sustainable food processing solutions. Some of the most common uses include increased production efficiency, improved texture, flavour, and shelf life, and reduced processing times in applications such as baking, dairy, brewing, and juice production. Additionally, consumer preferences for healthier and minimally processed foods will increasingly lead manufacturers to adopt enzyme-based solutions, thus boosting market growth.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The industrial enzymes market is segmented and analyzed as follows:

By Product

• Lipase
• Nuclease
• Carbohydrase
• Polymerase
• Others

By Source

• Animal
• Plant
• Microorganism
• Algae

By End-User Industry

• Food and Beverage
• Paper and Pulp
• Cosmetics
• Pharmaceutical
• Active Pharmaceutical Ingredients (API)
• In-Vitro Diagnostics
• Others
• Wastewater
• Animal Feed
• Others
• Healthcare
• Functional Foods
• Supplements
• Others
• Semiconductor
• Enzymes for Product Manufacturing
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• UAE
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. INDUSTRIAL ENZYMES MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Lipase
• 5.3. Nuclease
• 5.4. Carbohydrase
• 5.5. Polymerase
• 5.6. Others

6. INDUSTRIAL ENZYMES MARKET BY SOURCE

• 6.1. Introduction
• 6.2. Animal
• 6.3. Plant
• 6.4. Microorganism
• 6.5. Algae

7. INDUSTRIAL ENZYMES MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Water Treatment
• 7.3. Air Purification

8. INDUSTRIAL ENZYMES MARKET BY END-USER INDUSTRY

• 8.1. Introduction
• 8.2. Food and Beverage
• 8.3. Paper and Pulp
• 8.4. Cosmetics
• 8.5. Pharmaceutical
  • 8.5.1. Active Pharmaceutical Ingredients (API)
  • 8.5.2. In-Vitro Diagnostics
  • 8.5.3. Others
• 8.6. Wastewater
• 8.7. Animal Feed
• 8.8. Others
  • 8.8.1. Healthcare
    • 8.8.1.1. Functional Foods
    • 8.8.1.2. Supplements
    • 8.8.1.3. Others
  • 8.8.2. Semiconductor
    • 8.8.2.1. Enzymes for Product Manufacturing
    • 8.8.2.2. Others

9. INDUSTRIAL ENZYMES MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Product
  • 9.2.2. By Source
  • 9.2.3. By End-User Industry
  • 9.2.4. By Country
    • 9.2.4.1. USA
    • 9.2.4.2. Canada
    • 9.2.4.3. Mexico
• 9.3. South America
  • 9.3.1. By Product
  • 9.3.2. By Source
  • 9.3.3. By End-User Industry
  • 9.3.4. By Country
    • 9.3.4.1. Brazil
    • 9.3.4.2. Argentina
    • 9.3.4.3. Others
• 9.4. Europe
  • 9.4.1. By Product
  • 9.4.2. By Source
  • 9.4.3. By End-User Industry
  • 9.4.4. By Country
    • 9.4.4.1. United Kingdom
    • 9.4.4.2. Germany
    • 9.4.4.3. France
    • 9.4.4.4. Italy
    • 9.4.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Product
  • 9.5.2. By Source
  • 9.5.3. By End-User Industry
  • 9.5.4. By Country
    • 9.5.4.1. UAE
    • 9.5.4.2. Saudi Arabia
    • 9.5.4.3. Israel
    • 9.5.4.4. Others
• 9.6. Asia Pacific
  • 9.6.1. By Product
  • 9.6.2. By Source
  • 9.6.3. By End-User Industry
  • 9.6.4. By Country
    • 9.6.4.1. Japan
    • 9.6.4.2. China
    • 9.6.4.3. India
    • 9.6.4.4. South Korea
    • 9.6.4.5. Taiwan
    • 9.6.4.6. Thailand
    • 9.6.4.7. Indonesia
    • 9.6.4.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. ADM
• 11.2. DuPont t de Nemours Inc.
• 11.3. NOVOZYMES A/S
• 11.4. BASF SE
• 11.5. DSM-Firmenich
• 11.6. ABF Ingredients
• 11.7. Amano Enzyme Inc.
• 11.8. Lonza Group AG
• 11.9. Ginkgo Bioworks Holdings Inc.
• 11.10. Shin-Nihon Chemical Co., Ltd.
• 11.11. Thermo Fisher Scientific Inc.
• 11.12. LIVZYM
• 11.13. Kerry Group
• 11.14. AB Enzymes
• 11.15. Lumis Biotech Pvt. Ltd.